Munich-based platform Cellbyte provides pharmaceutical teams with a single AI-driven system that centralises all information.
Cellbyte has raised €2.4M across 1 funding round from 5 investors, most recently a Seed round in Nov 2025. Based in Munich, Germany; active in Software. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-11-19 | Seed | €2.4M |
| Frontline Ventures,Pace Ventures,Saras Capital,Springboard Health Angels,Y Combinator |
| View deal → |
